The past few years have been rough for psychedelic and shroom stocks, but recent news from ATAI (and Recognify), Compass Pathways and GH Research + positive regulatory tailwinds from RFK and MAHA make me think that Psychedelics are back on the menu in 2025.

In this video I discuss:

(0:00) - why psychedelics are hot again in 2025

(5:45) - latest thoughts on Compass a month after their Phase 3 topline data

(9:45) - thoughts on ATAI / Recognify, and how this feeds back into our psychedelic macro theme

Join our investing in psychedelics webinar www.psybio.org

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Brom Rector and Sam Tabone. Innehållet i podden är skapat av Brom Rector and Sam Tabone och inte av, eller tillsammans med, Poddtoppen.